Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthesis route for high-purity dibenzo oxepin intermediates offering cost reduction and supply reliability for pharmaceutical manufacturing processes.
Novel palladacycle catalyst enables high-yield aryl nitrile synthesis using safe potassium ferrocyanide, offering cost-effective pharma intermediate solutions.
Patent CN113735778B reveals efficient silver oxide promoted synthesis. Enables cost reduction and scalable supply chain for high purity pharmaceutical intermediates globally.
Novel one-pot synthesis of 3-acyl pyridines using copper/TEMPO catalysis. Offers high atom economy and mild conditions for reliable API intermediate manufacturing.
Patent CN115353511A details a safe, multi-component synthesis for carbonyl-bridged biheterocycles using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN111423381A details a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. Reduces cost in API manufacturing via safe CO sources and cheap nitro substrates.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN102180755A details a green synthesis of aryl azides using cuprous oxide in water. This method offers significant cost reduction and safety advantages for pharmaceutical manufacturing.
Patent CN113980044B details a novel Ir-O-P catalyzed C-H borylation method offering high yields and broad substrate scope for pharmaceutical intermediates.
Advanced Cu-catalyzed synthesis of 1-substituted-1,2,3-triazoles from patent CN101792438B. Offers high purity, scalable routes for pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN113105402B details a metal-free route to 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed carbonylation method for synthesizing carbonyl-bridged biheterocycles without toxic CO gas, offering safer pharmaceutical intermediate manufacturing.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel metal-free route for trifluoromethyl triazines. Reduces cost in API manufacturing with high purity and scalable conditions.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Patent CN113105402B reveals a metal-free route for 1,2,4-triazoles, offering cost reduction in API manufacturing and reliable pharmaceutical intermediate supply.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high efficiency and substrate compatibility for API manufacturing.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.